– The Alnylam Act ® program is a genetic testing initiative designed to enable improved patient diagnosis of three rare, devastating, and life-threatening genetic diseases – – Through the Alnylam Act ...
Base editors can correct disease-causing genetic variants. After a neonate had received a diagnosis of severe carbamoyl-phosphate synthetase 1 deficiency, a disease with an estimated 50% mortality in ...
In a recent article published in JAMA Network Open, researchers investigated the role of genetics in the phenotypic association between screen time and psychiatric problems using a large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results